Wendler, D. (2020). When and how to include vulnerable subjects in clinical trials. Clinical trials (London, England), 17(6), 696. https://doi.org/10.1177/1740774520945601
Chicago Style (17th ed.) CitationWendler, David. "When and How to Include Vulnerable Subjects in Clinical Trials." Clinical Trials (London, England) 17, no. 6 (2020): 696. https://doi.org/10.1177/1740774520945601.
MLA (9th ed.) CitationWendler, David. "When and How to Include Vulnerable Subjects in Clinical Trials." Clinical Trials (London, England), vol. 17, no. 6, 2020, p. 696, https://doi.org/10.1177/1740774520945601.
Warning: These citations may not always be 100% accurate.